United States: CMS Issues Final Rule For Fraud And Abuse Waivers In The Medicare Shared Savings Program

On October 29th, 2015, the Centers for Medicare and Medicaid Services (“CMS”) issued its final rule (“Final Rule”) for waivers of fraud and abuse laws in the context of the Medicare Shared Savings Program (“Shared Savings Program”). The Shared Savings Program utilizes accountable care organizations (“ACOs”) to encourage better care for individuals, better health for populations, and lower growth in health care expenditures. As discussed in the Final Rule, CMS continues to recognize that participation in the Shared Savings Program may require providers to integrate in ways that potentially implicate fraud and abuse laws. To alleviate these potential concerns, on November 2, 2011, CMS issued an interim final rule (“Interim Final Rule”) providing waivers for certain fraud and abuse laws. The differences between the Final Rule and the Interim Final Rule, are discussed below, along with a summary of the waivers as finalized by the Final Rule.

Final Rule Versus the Interim Final Rule

The Final Rule finalizes all five of the original waivers promulgated in the Interim Final, except for the changes discussed below.

(A comparison of the two iterations can be found here.)

1. Gainsharing CMP No Longer Waived due to MACRA

When the Interim Final Rule was originally published in 2011, hospitals were prohibited from knowingly making a payment, directly or indirectly, to induce a physician to reduce or limit any services. There was concern that the objectives of the Shared Savings Program — including the reduction of waste — could run afoul of the prohibition. As a result, the Interim Final Rule provided waivers for the reduction or limitation of medically unnecessary services in all five waivers. Subsequently, Section 512(a) of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) revised the Gainsharing CMP so that it prohibits reductions or limitations of medically necessary services. This narrowing of the prohibition to only medically necessary services eliminated the reason for including the Gainsharing CMP within the waivers. Consequently, references to the Gainsharing CMP have been removed from the finalized waivers.

2. Clarification Regarding Documentation Requirements

CMS has made relatively minor revisions to the wording of the waivers protecting ACO-start up and an ACO’s ongoing activities once it enters into a participation agreement. These waivers, known as the ACO Pre-Participation Waiver and the ACO Participation Waiver, both require that the arrangement, and its authorization by the governing body, be documented. In describing the documentation requirements, the Final Rule now clarifies that this documentation must (as opposed to “should”) include the governing body’s basis for determining that the ACO arrangement is reasonably related to the purposes of the Shared Savings Program. While swapping “must” for “should” may appear to be a substantive revision, the commentary to the Interim Final Rule left little doubt that the documentation must include the governing body’s basis for their determination.

3. Clarification of “Home Health Supplier”

Under both the Interim Final Rule and the Final Rule, the Pre-Participation Waiver does not cover arrangements involving drug and device manufacturers, distributors, durable equipment (DME) suppliers, or home health suppliers. (CMS carved out DME suppliers and home health suppliers due to CMS’ belief that these types of entities have historically posed a heightened risk of program abuse.) In response to a commenter pointing out that the term “home health supplier” does not have a specific meaning in the Medicare program, the Final Rule clarifies that, for purposes of the Final Rule, the term “home health supplier” means a provider, supplier or other entity that is primarily engaged in furnishing “home health services” as that term is defined in Section 1861(m) of the Social Security Act.

What Is (and Isn’t) “Reasonably Related” to the Purposes of the Shared Savings Program

In addition to the changes described above, CMS uses the commentary of the Final Rule to discuss a phrase contained in a number of exceptions: “reasonably related to the purposes of the Shared Savings Program.” CMS uses this phrase to require a nexus between the activity protected under a waiver and the purposes of the Shared Savings Program. In the Final Rule, CMS continues to define “purposes of the Shared Savings Program” in accordance with the Program’s statutory purposes, which include (1) promoting accountability for the quality, cost, and overall care for a Medicare population; (2) managing and coordinating care for Medicare fee-for-service beneficiaries through an ACO; and (3) encouraging investment in infrastructure and redesigned care processes for high quality and efficient service delivery for patients. As in the Interim Final Rule, CMS lists a number of examples of activities that are reasonably related to the purposes of the Shared Savings Program, including:

  • promoting evidence-based medicine and patient engagement;
  • meeting requirements for reporting on quality and cost measures;
  • coordinating care, such as through the use of telehealth, remote patient monitoring, and other enabling technologies;
  • establishing clinical and administrative systems for the ACOs;
  • meeting the clinical integration requirements of the Shared Savings Program;
  • meeting the quality performance standards of the Shared Savings Program;
  • evaluating health needs of the ACO’s assigned population;
  • communicating clinical knowledge and evidence-based medicine to beneficiaries; and
  • developing standards for beneficiary access and communication, including beneficiary access to medical records.

In the Interim Final Rule, CMS gave an example of an activity that would not be considered reasonably related to the purposes of the Shared Savings Program, namely, a per-referral payment (e.g., expressly paying a specialist $500 for every referral generated by the specialist or paying a nursing facility staff member $100 for every patient transported to the ACO’s hospital) as not being reasonably related to the purposes of the Shared Savings Program. In the Final Rule, CMS provides additional examples, including:

  • An arrangement whereby a physician, a physician practice, or other provider is required to pay a sum to receive ACO-related referrals (e.g., “pay-to-play” arrangements);
  • medical directorships or personal service arrangements where referring physicians or other providers receive payments for no actual services performed;
  • payments to induce a physician or other provider to stint on medically necessary care for beneficiaries; or
  • free gifts, such as sporting event tickets, to referring ACO providers/suppliers or ACO participants.

These arrangements, CMS states, are suspect and subject to ordinary case-by-case review under all applicable fraud and abuse laws.

Summary of the Waivers Finalized in the Final Rule

The Final Rule finalizes the following five waivers, each of which is summarized below.

1. ACO Pre-Participation Waiver

The ACO Pre-Participation Waiver waives the physician self-referral law (“Stark Law”) and the Federal anti-kickback statute (“AKS”). It applies to ACO-related start-up arrangements in anticipation of participating in the Shared Savings Program. CMS has provided a list of activities that it believes are representative of the types of start-up arrangements that ACOs enter into, and that may qualify under the ACO Pre-Participation Waiver. These activities include, for example, infrastructure creation, network development, care coordination mechanisms, clinical management systems, hiring of new staff, information technology systems (including EHR systems), and a number of other activities. However, just because one engages in these activities does not mean they qualify for the waiver: like the Interim Final Rule, the Final Rule sets forth certain criteria that must be satisfied in order to take advantage of this waiver’s protection. Specifically, this waiver requires that:

(i) the arrangement must be undertaken with the good faith intent to develop an ACO that will participate in the Shared Savings Program;

(ii) the parties developing the ACO must be taking diligent steps to develop an ACO that would be eligible for a participation agreement that would be become effective during the target year;

(iii) the ACO’s governing body has made and duly authorized a bona fide determination that the arrangement is reasonably related to the purposes of the shared savings program;

(iv) the arrangement, its authorization, and the steps taken to develop the ACO are documented;

(v) the description of the arrangement is publicly disclosed, pursuant to the following guidance (such disclosure shall not include the financial or economic terms of the arrangement); and

(vi) if an ACO does not submit an application for a participation agreement by the last available application due date for the target year, the ACO must submit a statement describing the reasons it was unable to submit an application.

The duration of this waiver varies depending on the specific facts of the ACO. Generally, the waivers begin one year preceding their application due date and end either when the ACO enters into a participation agreement, when the ACO has their application denied, or for those ACOs failing to submit an application, on the earlier of the due date or when the ACO submits a statement of reasons for failing to submit an application.

2. ACO Participation Waiver

The ACO Participation Waiver waives the Stark Law and the AKS with respect to any arrangement of an ACO, one or more of its ACO participants or its ACO providers/suppliers, or a combination thereof. To take advantage of this waiver, the following criteria must be satisfied:

(i) the ACO has entered into a participation agreement and remains in good standing;

(ii) the ACO satisfies certain governance, leadership and management requirements;

(iii) the ACO’s governing body has made and duly authorized a bona fide determination that the arrangement is reasonably related to the purposes of the Shared Savings Program;

(iv) the arrangement and its authorization are documented; and

(v) the description of the arrangement is publicly disclosed, pursuant to the following guidance (such disclosure shall not include the financial or economic terms of the arrangement).

Arrangements satisfying the above criteria are eligible for the waiver starting on the date of their participation agreement and ending 6 months after the earlier of the expiration of the participation agreement (including any renewals) or the date on which the ACO has voluntarily terminated the participation agreement. If CMS terminates the participation agreement, the waiver period will end on the date of the termination notice.

3. Shared Savings Distribution Waiver

The Shared Savings Distribution Waiver waives the Stark Law and the AKS with respect to distributions or use of shared savings earned by an ACO, provided that all of the following conditions are satisfied:

(i) the ACO has entered into a participation agreement and remains in good standing;

(ii) the shared savings are earned by the ACO pursuant to the Shared Savings Program;

(iii) the shared savings are earned by the ACO during the term of its participation agreement, even if the actual distributions or use of the shared savings occurs after the expiration of the agreement; and

(iv) the shared savings are distributed during the year in which the shared savings were earned by the ACO, or were used for activities that are reasonably related to the purposes of the Shared Savings Program.

4. Compliance with the Stark Law Waiver

The Compliance with the Physician Self-Referral Law Waiver waives the AKS with respect to any financial relationship between or among the ACO, its ACO participants, and its ACO providers/suppliers that implicates the physician self-referral law, provided all of the following conditions are met:

(i) the ACO has entered into a participation agreement and remains in good standing;

(ii) the financial relationship is reasonably related to the purposes of the Shared Savings Program; and

(iii) the financial relationship satisfies one of the exceptions to Stark Law set forth in 42 CFR 411.355 through 357.

The waiver period for this waiver begins on the start date of the participation agreement and ends on the earlier of the expiration of the term of the participation agreement (including any renewals) or the date on which the participation agreement has been terminated.

5. Patient Incentive Waiver

The Patient Incentive Waiver waives the AKS as well as the Beneficiary Inducements CMP provisions with respect to items or services provided by an ACO, its ACO participants, or its ACO providers/suppliers to beneficiaries for free or below fair market value, provided that four criteria are satisfied:

(i) the ACO has entered into a participation agreement and remains in good standing;

(ii) there is a reasonable connection between the items or services and the medical care of the beneficiary;

(iii) the items or services are in-kind; and

(iv) the items or services relate to preventive care, the advancement of clinical goals or the management of a chronic disease or condition.

The waiver period for this waiver begins on the date of the participation agreement and ends on the earlier of the expiration of the term of the participation agreement (including any renewals) or the date on which the participation agreement has been terminated. Beneficiaries may keep items received before the participation agreement expired or was terminated, and can receive the remainder of any service initiated before the termination or expiration.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.